Molecular docking study of the phytol and its derivatives against COX-2 induced inflammation: A combined density functional study
This study aimed to determine the activity of PYT and its derivatives against COX-2, including 5IKR protein induced inflammation by using the computational tools. PYT and its derivatives have been designed by utilizing density functional theory (DFT) and the performance of the drugs was also evaluated by molecular docking study. Results suggest that the NH2 derivative of PYT (D-NH2) showed binding energy -6.4 (Kcal/mol) with protein 5IKR of COX-2 compared to the main drug (D) that showed binding energy -5.1 (Kcal/mol) with the same protein. HOMO and LUMO energy values were also calculated to determine the chemical reactivity of all the modified drugs. Non-covalent interactions of PYT and its derivatives were essential in improving the performance. In conclusion, D-NH2 showed better preference in inhibiting to the protein 5IKR of COX-2 compared to other modified drugs and it can be claimed that D-NH2 will be the best conformer for COX-2 induced inflammation.
2. Ishibashi Y, Nagamatsu Y, Miyamoto T, Matsunaga N, Okino N, Yamaguchi K, Ito M. 2014, A novel ether-linked phytol containing digalactosyl glycero lipid in the marine green alga, Ulva pertusa Biochem Biophys Res Commun. 52:873-80.
3. Costa JP, de Oliveira GAL, de Almeida AAC, Islam MT, de Sousa DP, Freitas RM. 2014, Anxiolytic-like effects of phytol: possible involvement of GABAergic transmission. Brain Res. 1547:34-42.
4. Santos CC, Salvadori MS, Mota VG, Costa LM, de Almeida AA, de Oliveira GA, et al. 2013, Antinociceptive and antioxidant activities of phytol in vivo and in vitro models. Neurosci J. 2013:949452.
5. Elmazar MM, El-Abhar HS, Schaalan MF, Farag NA. 2013, Phytol/ phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations. PLoS One 8:45638.
6. Silva RO, Sousa FB, Damasceno SR, Carvalho NS, Silva VG, Oliveira FR, et al. 2014, Phytol, a diterpene alcohol, inhibits the inflammatory response by reducing cytokine production and oxidative stress. Fundam Clin Pharmacol. 28:455-64.
7. Arnhold T, Elmazar MMA, Nau H. 2002, Prevention of vitamin A teratogenesis by phytol or phytanic acid results from reduced metabolism of retinol to the teratogenic metabolite, all-transretinoic acid. Toxicol Sci. 66:274-82.
8. Costa JP, Ferreira PB, De Sousa DP, Jordan J, Freitas RM. 2012, Anticonvulsant effect of phytol in a pilocarpine model in mice. Neurosci Lett.523:115-8.
9. Pongprayoon U, Baeckstr€om P, Jacobsson U, Lindstr€om M, Bohlin L. 1992, Antispasmodic activity of beta-damascenone and E-PHY isolated from Ipomoea pes-caprae. Planta Med. 58:19-21.
10. Kagoura M, Matsui C, Morohashi M. 1993, Carcinogenicity study of phytol (3,7,11,15-tetramethyl-2-hexadecen-1-ol) in ICR mice. J Investig Dermatol. 101:460.
11. Bero J, Beaufay C, Hannaert V, Hérent MF, Michels PA, Quetin-Leclercq J. 2013, Antitrypanosomal compounds from the essential oil and extracts of Keetia leucantha leaves with inhibitor activity on Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase. Phytomedicine. 20:270-4.
12. Inoue Y, Hada T, Shiraishi A, Hirose K, Hamashima H, et al. 2005, Biphasic effects of geranylgeraniol, teprenone, and phytol onthe growth of Staphylococcus aureus.Antimicrob Chemother Agents Chemother. 49:1770-4.
13. Takahashi N, Kawada T, Goto T, Yamamoto T, Taimatsu A, Matsui N, et al. 2002, Dual action of isoprenols from herbal medicines on both PPARg and PPARa in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 514:315-22.
14. Lim SY, Bauermeister A, Kjonaas RA, Ghosh SK. 2006, Phytolbased novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice. J Immune Based Ther Vacc.4:5.
15. Minghetti L. 2004, Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 63:901-10.
16. Vane JR. 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 231:232-5.
17. Smith WL, Garavito RM, DeWitt DL. 1996, Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 271:33157-60.
18. Eberhart CE, Dubois RN. 1995, Eicosanoids and the gastrointestinal tract. Gastroenterology. 109:285-301.
19. Gleeson MP, Gleeson D. 2009, QM/MM calculations in drug discovery: a useful method for studying binding phenomena? J Chem Information Modeling. 49:670-7.
20. Rahman A, Ali MT, Shawan MMAK, Sarwar MG, Khan MA, Halim MA. 2016, Halogen-directed drug design for Alzheimer’s disease: a combined density functional and molecular docking study. SpringerPlus. 5:1346. 21. Parr RG, Yang W. 1989, Density-Functional Theory of Atoms and Molecules (New York: Oxford University Press).
22. Morris GM, Lim-Wilby M. 2008, Molecular docking. Methods Mol Biol. 443:365-82.
23. Bissantz C, Kuhn B, Stahl M. 2010, A medicinal chemist’s guide to molecular interactions. J Med Chem. 53:5061-84.
24. Rehman S, Nabi B, Fazil M, Khan S, Bari NK, Singh R, Ali J. Role of P-2017, Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir. BioMed Res Int. doi: 10.1155/2017/8274927.